(Q42521824)

English

The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

desensitization

1 reference

based on heuristic

inferred from title

Stefano Marullo

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

author name string

Malin C Levin

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Olivier Muntaner

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Bert Andersson

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Yvonne Magnusson

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

28 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

277

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

30429-30435

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

beta-adrenergic receptor blockade in chronic heart failure

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Rapid and efficient site-specific mutagenesis without phenotypic selection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Constitutively active mutants of the beta1-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Interaction with beta-arrestin determines the difference in internalization behavor between beta1- and beta2-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Mutation of Asn111 in the third transmembrane domain of the AT1A angiotensin II receptor induces its constitutive activation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosph

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Structure-based conformational preferences of amino acids

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Uncovering molecular mechanisms involved in activation of G protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Characterization of a Unique Genetic Variant in the β1-adrenoceptor Gene and Evaluation of its Role in Idiopathic Dilated Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200681200

21 January 2018

Identifiers

10.1074/JBC.M200681200

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42521824&oldid=1960535303"